Cory L. Brooks

952 total citations
44 papers, 691 citations indexed

About

Cory L. Brooks is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Cory L. Brooks has authored 44 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Cory L. Brooks's work include Glycosylation and Glycoproteins Research (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Escherichia coli research studies (5 papers). Cory L. Brooks is often cited by papers focused on Glycosylation and Glycoproteins Research (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Escherichia coli research studies (5 papers). Cory L. Brooks collaborates with scholars based in United States, Canada and Germany. Cory L. Brooks's co-authors include M. Joanne Lemieux, Stephen V. Evans, Sven Müller‐Loennies, Gary B. Dunphy, Helmut Brade, Paul Kosma, Lore Brade, Teresa M. Brooks, Tomoko Hirama and Geert‐Jan Boons and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Cory L. Brooks

43 papers receiving 678 citations

Peers

Cory L. Brooks
Jason S. Rush United States
Roberta Fuller United States
Andrew J. Fadden United Kingdom
Cummings Rd United States
Yao‐Yun Fan Switzerland
Jason S. Rush United States
Cory L. Brooks
Citations per year, relative to Cory L. Brooks Cory L. Brooks (= 1×) peers Jason S. Rush

Countries citing papers authored by Cory L. Brooks

Since Specialization
Citations

This map shows the geographic impact of Cory L. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory L. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory L. Brooks more than expected).

Fields of papers citing papers by Cory L. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cory L. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory L. Brooks. The network helps show where Cory L. Brooks may publish in the future.

Co-authorship network of co-authors of Cory L. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Cory L. Brooks. A scholar is included among the top collaborators of Cory L. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cory L. Brooks. Cory L. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caffrey, Thomas C., Ying Huang, Aaron M. Mohs, et al.. (2025). Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. Cancers. 17(6). 957–957.
2.
Bauer, David, Lukas M. Carter, Sebastian E. Carrasco, et al.. (2024). Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer. Nuclear Medicine and Biology. 140-141. 108976–108976. 1 indexed citations
3.
Brooks, Cory L., et al.. (2022). X-ray Crystal Structure Analysis of VHH–Protein Antigen Complexes. Methods in molecular biology. 2446. 513–530. 6 indexed citations
4.
Sharma, Sai Kiran, Alessandra Piersigilli, Jacob Pourat, et al.. (2021). ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody. Clinical Cancer Research. 28(5). 948–959. 29 indexed citations
5.
Singh, Jaideep, et al.. (2019). Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope. Journal of Peptide Science. 26(1). e3229–e3229. 3 indexed citations
6.
Brooks, Cory L., Martín A. Rossotti, & Kevin A. Henry. (2018). Immunological Functions and Evolutionary Emergence of Heavy-Chain Antibodies. Trends in Immunology. 39(12). 956–960. 15 indexed citations
7.
Brooks, Cory L., et al.. (2018). Epitope Mapping of Antibody-Antigen Interactions with X-Ray Crystallography. Methods in molecular biology. 1785. 13–27. 44 indexed citations
8.
Brooks, Teresa M., et al.. (2018). Structural basis of VHH-mediated neutralization of the food-borne pathogen Listeria monocytogenes. Journal of Biological Chemistry. 293(35). 13626–13635. 27 indexed citations
9.
Smith, David F., Richard D. Cummings, Cory L. Brooks, et al.. (2015). Single-chain antibody-fragment M6P-1 possesses a mannose 6-phosphate monosaccharide-specific binding pocket that distinguishesN-glycan phosphorylation in a branch-specific manner. Glycobiology. 26(2). 181–192. 9 indexed citations
10.
Park, Jin, Cory L. Brooks, José Serate, et al.. (2015). Directed Evolution of the Escherichia coli cAMP Receptor Protein at the cAMP Pocket. Journal of Biological Chemistry. 290(44). 26587–26596. 10 indexed citations
11.
Brooks, Cory L., Elena Arutyunova, & M. Joanne Lemieux. (2014). The structure of lactoferrin-binding protein B fromNeisseria meningitidissuggests roles in iron acquisition and neutralization of host defences. Acta Crystallographica Section F Structural Biology Communications. 70(10). 1312–1317. 21 indexed citations
12.
MacKenzie, C. Roger, et al.. (2014). In situproteolysis, crystallization and preliminary X-ray diffraction analysis of a VHH that binds listeria internalin B. Acta Crystallographica Section F Structural Biology Communications. 70(11). 1532–1535. 5 indexed citations
13.
Brooks, Cory L., Melissa Morrison, & M. Joanne Lemieux. (2013). Rapid expression screening of eukaryotic membrane proteins in Pichia pastoris. Protein Science. 22(4). 425–433. 22 indexed citations
14.
Brooks, Cory L., Paul Kosma, Sven Müller‐Loennies, et al.. (2012). Exploring the cross-reactivity of S25-2: complex with a 5,6-dehydro-Kdo disaccharide. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 69(1). 2–5. 6 indexed citations
15.
Evans, David W., Sven Müller‐Loennies, Cory L. Brooks, et al.. (2011). Structural insights into parallel strategies for germline antibody recognition of lipopolysaccharide from Chlamydia. Glycobiology. 21(8). 1049–1059. 14 indexed citations
16.
Brooks, Cory L., et al.. (2011). Insights into Substrate Gating in H. influenzae Rhomboid. Journal of Molecular Biology. 407(5). 687–697. 29 indexed citations
17.
Brooks, Cory L., Paul Kosma, Lore Brade, et al.. (2009). Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci. Glycobiology. 20(4). 461–472. 24 indexed citations
18.
Brooks, Cory L., Paul Kosma, Sven Müller‐Loennies, et al.. (2009). The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen. Glycobiology. 20(2). 138–147. 12 indexed citations
19.
Brooks, Cory L., et al.. (2008). Pseudo-symmetry and twinning in crystals of homologous antibody Fv fragments. Acta Crystallographica Section D Biological Crystallography. 64(12). 1250–1258. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026